INVESTBOARDLog in
Healthcare · Medical Devices · SE

Episurf Medical AB (publ) EPIS-B

kr0.06 · close of Nov 6, 2026
AI score · Average · analysis Jan 30, 2026
4.6 of 10

Valuation holds this up; Risk is the soft spot.

Moat4.0
Management3.0
Valuation7.0
Risk · 10 = lowest3.0
Business model5.0
Optionality5.0
Fair value
AI fair value
kr0.02
as of Nov 10, 2026
Base case
kr0.02
the single most likely path
Analyst consensus
—
12-month target
Price
kr0.06
price 177% above the AI fair value

The AI thinks 28.0% is achievable, at a 42.0% margin.

Strong platform moat and regulatory catalysts (MTP FDA, US ramp) support 28% sustainable growth exceeding current EV/rev multiple; pipeline rNPV adds 50-100% upside to mcap.

The business

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also offers Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient's distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. It also holds logistics and warehouse properties in Helsinki and Kerava. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.

Last report Jun 30, 2026

Write why this business works, set your own fair value, and let the briefing speak only when a rule you wrote is crossed.

Start the thirty days · no card
General investment analysis · not personalized advice · the figures carry their dates